Solitary Plasmacytoma in the Calcaneus.
calcaneus
plasma cell dyscrasias
plasma cell tumor
plasmacytoma
trauma
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
accepted:
16
04
2023
medline:
18
5
2023
pubmed:
18
5
2023
entrez:
18
5
2023
Statut:
epublish
Résumé
Solitary plasmacytomas (SPs) are tumors characterized by local monoclonal plasma cell proliferation, presenting without systemic manifestations. It mainly affects the axial skeleton, with calcaneal involvement being extremely rare. We report a case of a 48-year-old patient with a history of gunshot injury to his foot who presented with worsening heel pain and a calcaneal cyst. Biopsy revealed plasmacytoma, and subsequent 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) scan further supported the diagnosis of solitary plasmacytoma of the bone (SPB). Management included lesion excision, bone cement placement, and radiotherapy. However, due to recurrent osteomyelitis following cement placement, the patient eventually required total calcanectomy. SPB usually affects older adults, and developing the disease at a young age and in the calcaneus is exceedingly uncommon. Trauma is implicated as a possible inciting trigger in the pathogenesis of SPB without a clear association. This case highlights the importance of developing our current understanding of the clinical presentation and manifestations of SPB, beyond the conventional assumption that it only affects the axial skeleton of older individuals.
Identifiants
pubmed: 37200639
doi: 10.7759/cureus.37637
pmc: PMC10187489
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e37637Informations de copyright
Copyright © 2023, Albandak et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Leuk Lymphoma. 1996 May;21(5-6):505-7
pubmed: 9172818
Cancer. 2011 Oct 1;117(19):4468-74
pubmed: 21437886
Blood. 2003 Mar 1;101(5):1715-7
pubmed: 12393501
Curr Treat Options Oncol. 2002 Jun;3(3):255-9
pubmed: 12057071
Blood. 2000 Sep 15;96(6):2037-44
pubmed: 10979944
Leuk Res. 2010 Aug;34(8):e181-2
pubmed: 20452020
Int J Clin Exp Pathol. 2012;5(5):463-7
pubmed: 22808301
JNMA J Nepal Med Assoc. 2019 Sep-Oct;57(219):373-375
pubmed: 32329469
Blood. 2014 Aug 21;124(8):1296-9
pubmed: 24939658
Medicine (Baltimore). 2021 Jul 2;100(26):e26568
pubmed: 34190199
ScientificWorldJournal. 2012;2012:895765
pubmed: 22654647
Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):210-7
pubmed: 16229966
Br J Haematol. 2016 Feb;172(4):554-60
pubmed: 26684545
Clin Cancer Res. 2014 Jun 15;20(12):3254-60
pubmed: 24714772
J Hematol Oncol. 2018 Jan 16;11(1):10
pubmed: 29338789
Lancet Oncol. 2014 Nov;15(12):e538-48
pubmed: 25439696
Am Soc Clin Oncol Educ Book. 2016;35:e418-23
pubmed: 27249749
Mediterr J Hematol Infect Dis. 2017 Aug 23;9(1):e2017052
pubmed: 28894561